The drug maker Rite Aid will pay $4 million in fines to U.S. authorities over its Iran-related marketing and sales of a medication that is believed to be contaminated with the highly contagious hepatitis B virus.

The company has pleaded guilty to conspiracy to commit money laundering, according to The Wall Street Journal.

Rite Aid agreed to pay a $3 million fine and a $1.25 million fine to the Justice Department and the U.K.’s Serious Fraud Office.

Rita Reiman, Rite Aid’s director of global health, will receive a $5 million fine for violating a federal law known as the Commodity Exchange Act, the Journal reported.

Rice, who has not been charged with any crimes, was one of the executives who signed off on the deal, according the Journal.

The drugmaker also agreed to provide an independent audit to Congress, as well as to pay $1 million in restitution to the United States for violating sanctions against Iran.